Professor Hany Ariffin  is  Professor of Paediatrics and Head of the Division of Paediatric Haematology-Oncology and Blood & Marrow Transplantation at the University of Malaya Medical Centre (UMMC). She also heads the Biobank Unit in the Faculty of Medicine, UM.  Her main research interest is childhood leukaemia and she has been the Malaysian lead for the Malaysia-Singapore (MASPORE) Leukaemia Study Group since 2003. Her other research areas include childhood cancer survivorship, stem cell transplantation and inherited cancers, particularly related to mutations in the tumour suppressor gene, TP53. In 2015, she won the Anugerah Akademik Negara award and in 2018 received the Distinguished Researcher Award from University Malaya. Professor Hany is chairperson of the paediatric oncology accreditation committee for the National Specialist Register and a past president of the Malaysian Society of Paediatric Haematology-Oncology. She is also the chairperson of the VIVA-Asia Bone Marrow Transplantation Consortium for 2023/2024.  As co-chair of the Asian Childhood Cancer Alliance, Professor Hany works with regional colleagues as well as StJude Children's Research Hospital  to support the WHO Global Initiative for Childhood Cancer (WHO-GICC). The project's tagline is: “60 by 30” - which refers to the aim of reaching at least a 60% survival rate for children with cancer by 2030, thereby saving an additional one million lives around the world.  Professor Hany has been a reviewer for many scientific journals and is currently an Associate Editor (Tumour Biology) for Technology in Cancer Reseach &Treatment.